SCHEMBL6777121

SCHEMBL6777121

O=C(O)CCCN1CCC(c2cn(Cc3ccc(F)cc3)c3ccccc23)CC1

nearest known ligand 0.62

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.62
HTR6 P50406 2/20 0.62
HRH2 P25021 10/20 0.54
HTR2A P28223 2/20 0.52
HTR2C P28335 2/20 0.52
HTR2B P41595 2/20 0.52
SLC5A1 P13866 1/20 0.52
SLC5A2 P31639 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6780420 0.94 DRD2 (0.59) DRD2HTR6HRH2HTR2AHTR2C
SCHEMBL6775869 0.88 HRH2 (0.62) DRD2HTR6HRH2HTR2AHTR2C
SCHEMBL4061970 0.85 CNR1 (0.51) DRD2HTR6HRH2HTR2AHTR2C
SCHEMBL6777249 0.85 DRD2 (0.78) DRD2HTR6HRH2HTR2AHTR2C
SCHEMBL6775932 0.82 HRH2 (0.68) DRD2HTR6HRH2HTR2AHTR2C
SCHEMBL6786458 0.82 HTR2A (0.77) DRD2HTR6HRH2HTR2AHTR2C
SCHEMBL6782119 0.81 HRH2 (0.64) HRH2HTR2AHTR2CHTR2B
SCHEMBL6779928 0.81 HRH2 (0.54) DRD2HTR6HRH2HTR2AHTR2C
SCHEMBL6777709 0.81 LMNA (0.56) DRD2HTR6HRH2HTR2AHTR2C
SCHEMBL27494197 0.79 ALDH1A1 (0.59) DRD2HTR6HRH2SLC5A1SLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1191246-C Indolylpiperidine derivatives as antihistamines and antiallergic agents ALMIRALL PRODESFARMA SA (ES) 2005-03-02 CN claimed
EP-1183251-B1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA SA (ES) 2004-02-11 EP claimed
US-6683096-B2 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2004-01-27 US claimed
US-20020147344-A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2002-10-10 US claimed
EP-1183251-B1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA SA (ES) 2004-02-11 EP disclosed
US-6683096-B2 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2004-01-27 US disclosed
US-20020147344-A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2002-10-10 US disclosed
CN-1368969-A Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA SA (ES) 2002-09-11 CN disclosed
EP-1183251-A1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS Almirall Prodesfarma, S.A. (ES) 2002-03-06 EP disclosed
WO-2000075130-A1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA, S.A. (ES) 2000-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147344-A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents HRH2, HRH1, HRH4 DRD2 79/4885HTR6 26/4885HRH2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.